1. Home
  2. PDSB vs TPCS Comparison

PDSB vs TPCS Comparison

Compare PDSB & TPCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PDSB
  • TPCS
  • Stock Information
  • Founded
  • PDSB 2005
  • TPCS 1956
  • Country
  • PDSB United States
  • TPCS United States
  • Employees
  • PDSB N/A
  • TPCS N/A
  • Industry
  • PDSB Biotechnology: Pharmaceutical Preparations
  • TPCS Metal Fabrications
  • Sector
  • PDSB Health Care
  • TPCS Industrials
  • Exchange
  • PDSB Nasdaq
  • TPCS Nasdaq
  • Market Cap
  • PDSB 48.0M
  • TPCS 51.4M
  • IPO Year
  • PDSB N/A
  • TPCS N/A
  • Fundamental
  • Price
  • PDSB $0.96
  • TPCS $5.48
  • Analyst Decision
  • PDSB Strong Buy
  • TPCS
  • Analyst Count
  • PDSB 2
  • TPCS 0
  • Target Price
  • PDSB $10.00
  • TPCS N/A
  • AVG Volume (30 Days)
  • PDSB 510.9K
  • TPCS 30.4K
  • Earning Date
  • PDSB 11-13-2025
  • TPCS 08-21-2025
  • Dividend Yield
  • PDSB N/A
  • TPCS N/A
  • EPS Growth
  • PDSB N/A
  • TPCS N/A
  • EPS
  • PDSB N/A
  • TPCS N/A
  • Revenue
  • PDSB N/A
  • TPCS $33,424,000.00
  • Revenue This Year
  • PDSB N/A
  • TPCS N/A
  • Revenue Next Year
  • PDSB N/A
  • TPCS N/A
  • P/E Ratio
  • PDSB N/A
  • TPCS N/A
  • Revenue Growth
  • PDSB N/A
  • TPCS 3.78
  • 52 Week Low
  • PDSB $0.85
  • TPCS $2.05
  • 52 Week High
  • PDSB $3.79
  • TPCS $6.25
  • Technical
  • Relative Strength Index (RSI)
  • PDSB 28.87
  • TPCS 57.27
  • Support Level
  • PDSB $1.00
  • TPCS $5.18
  • Resistance Level
  • PDSB $1.05
  • TPCS $5.67
  • Average True Range (ATR)
  • PDSB 0.05
  • TPCS 0.20
  • MACD
  • PDSB -0.01
  • TPCS -0.00
  • Stochastic Oscillator
  • PDSB 5.29
  • TPCS 77.90

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

About TPCS TechPrecision Corporation Common stock

Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components. It derives maximum revenue from Ranor segment.

Share on Social Networks: